$50 Million Burrill-Bayer VC Fund Now to Close By End-2002

Aug 29, 2002

NEW YORK, Aug. 29 - A biotech venture capital fund launched in January by Burrill & Company and Bayer Diagnostics has secured half of the $50 million originally slated to close by June.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Enzo Biochem Lands NYS Approval for Bacterial Vaginosis Test
Vantari Genetics, Translational Software to Genotype Patients for Alzheimer's Research Program
Top Five Articles on GenomeWeb Last Week: Illumina Ventures, AstraZeneca, ASHG, and More
TBG Biotechnology Wins Chinese Approval for HLA Typing Kits
In Brief This Week: WuXi NextCode, 10x Genomics, Synthego, and More
People in the News: Carlos Bustamante, Douglas Berthiaume, Christopher O'Connell, and More

The Scan

Who Are You?

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

'Problematic'

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Republicans Take on Peer Review

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

This Week in Science

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.

Main menu